PPARA and acute respiratory distress syndrome: Novel strategies targeting HMGB1, such as glycyrrhizin [37], gabexate mesilate [37], ethyl pyruvate [38, 39], and PPAR ligands [40] that interfere with asbestos-mediated inflammation, may prevent or delay ARDs onset and relieve the progress of malignant ARDs.